<--- Back to Details
First PageDocument Content
Infectious diseases / Rhinology / Bacterial diseases / Headaches / Sinusitis / Anaerobic infection / Sinus / Itzhak Brook / Paranasal sinuses / Medicine / Health / General practice
Date: 2011-04-19 14:56:27
Infectious diseases
Rhinology
Bacterial diseases
Headaches
Sinusitis
Anaerobic infection
Sinus
Itzhak Brook
Paranasal sinuses
Medicine
Health
General practice

Microsoft Word - PediatricSuperSiteReview(PSINU)

Add to Reading List

Source URL: www.pcibooks.com

Download Document from Source Website

File Size: 189,99 KB

Share Document on Facebook

Similar Documents

What you need to know about… The paranasal sinuses are a group of air-filled cavities located in the facial area. The maxillary sinuses are located under

DocID: 1ur9X - View Document

Medical equipment / Medical technology / Propel mometasone furoate implant / RTT / Sinus implant / Sinusitis / Intersect ENT / Sinus / Otorhinolaryngology / Paranasal sinuses / Frontal sinus / Balloon sinuplasty

Intersect ENT Announces FDA Approval of Additional Indication for PROPEL® Mini Sinus Implant PROPEL Mini Now Indicated to Treat Patients With Frontal Sinus Disease MENLO PARK, Calif.—March 23, 2016—Intersect ENT, In

DocID: 1mCRC - View Document

Medicine / Medical equipment / Medical technology / Propel mometasone furoate implant / Sinus implant / Intersect ENT / Sinusitis / Sinus / Otorhinolaryngology / Paranasal sinuses / Frontal sinus / Ethmoid sinus

Intersect ENT Announces Positive Preliminary Clinical Results for the PROPEL Mini Steroid Releasing Implant in Patients with Frontal Sinus Disease Menlo Park, Calif. – August 17, 2015 – Intersect ENT, Inc. (Nasdaq:XE

DocID: 1lN0M - View Document

Medicine / Medical equipment / Medical technology / Propel mometasone furoate implant / Intersect ENT / RTT / Sinus implant / Sinusitis / Sinus / Otorhinolaryngology / Frontal sinus / Paranasal sinuses

Intersect ENT Announces FDA Submission to Seek Expanded Indication of PROPEL Mini Steroid Releasing Implant to Treat Patients With Frontal Sinus Disease MENLO PARK, Calif.—September 29, 2015—Intersect ENT, Inc. (Nasd

DocID: 1l9KI - View Document

Medical technology / Medical equipment / Propel mometasone furoate implant / Sinus implant / RTT / Sinusitis / Intersect ENT / Sinus / Otorhinolaryngology / Paranasal sinuses / Balloon sinuplasty / Sinus lift

Intersect ENT Announces Positive Clinical Results from Three Studies Evaluating Steroid Releasing Implants Placed in the Physician’s Office Menlo Park, Calif. and Dallas, Texas – September 28, 2015 – Intersect ENT,

DocID: 1kvXr - View Document